Furthermore, during infection and cancer, A2AR engagement seems to inhibit via IL-15 signaling blockade, the generation of human CD39+NK cells endowed with a potent degranulation capacity and overexpression of IFNγ and TNFα (111). The gene discussed is ADORA2A; the disease is cancer.